Haleon plc (HLN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Haleon plc (HLN) has a cash flow conversion efficiency ratio of 0.090x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.48 Billion) by net assets ($16.46 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Haleon plc balance sheet independence to measure how much of total assets are equity-financed.
Haleon plc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Haleon plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check HLN cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Haleon plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Haleon plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ameriprise Financial Inc
NYSE:AMP
|
0.074x |
|
Erste Group Bank AG
VI:EBS
|
0.070x |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
-0.236x |
|
Block, Inc
NYSE:XYZ
|
0.045x |
|
Sysco Corporation
NYSE:SYY
|
0.225x |
|
Legrand SA
PA:LR
|
0.059x |
|
LEGRAND UNSP.ARD 1/5 EO 4
F:LRC0
|
0.033x |
|
ArcelorMittal SA
AS:MT
|
0.000x |
Annual Cash Flow Conversion Efficiency for Haleon plc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Haleon plc from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see HLN stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $16.46 Billion | $2.29 Billion | 0.139x | -2.06% |
| 2024-12-31 | $16.22 Billion | $2.30 Billion | 0.142x | +12.98% |
| 2023-12-31 | $16.73 Billion | $2.10 Billion | 0.126x | +0.14% |
| 2022-12-31 | $16.46 Billion | $2.06 Billion | 0.125x | +144.80% |
| 2021-12-31 | $26.48 Billion | $1.36 Billion | 0.051x | -4.56% |
| 2020-12-31 | $26.22 Billion | $1.41 Billion | 0.054x | +87.12% |
| 2019-12-31 | $27.41 Billion | $786.00 Million | 0.029x | -- |
About Haleon plc
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; an… Read more